Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Long-Term Debt Repayments: 2010-2013

Historic Long-Term Debt Repayments for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to $575,000.

  • Sonoma Pharmaceuticals' Long-Term Debt Repayments rose 92.31% to $575,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $2.1 million, marking a year-over-year increase of 78.95%. This contributed to the annual value of $120,000 for FY2023, which is 300.00% up from last year.
  • Sonoma Pharmaceuticals' Long-Term Debt Repayments amounted to $575,000 in Q1 2013, which was up 7.68% from $534,000 recorded in Q4 2012.
  • Over the past 5 years, Sonoma Pharmaceuticals' Long-Term Debt Repayments peaked at $575,000 during Q1 2013, and registered a low of $54,000 during Q4 2010.
  • Its 3-year average for Long-Term Debt Repayments is $383,889, with a median of $318,000 in 2011.
  • Data for Sonoma Pharmaceuticals' Long-Term Debt Repayments shows a peak YoY spiked of 437.04% (in 2011) over the last 5 years.
  • Quarterly analysis of 4 years shows Sonoma Pharmaceuticals' Long-Term Debt Repayments stood at $54,000 in 2010, then spiked by 437.04% to $290,000 in 2011, then skyrocketed by 84.14% to $534,000 in 2012, then surged by 92.31% to $575,000 in 2013.
  • Its Long-Term Debt Repayments was $575,000 in Q1 2013, compared to $534,000 in Q4 2012 and $507,000 in Q3 2012.